1,2,4-triazole has been researched along with Neuralgia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, Y; Welsh, WJ; Zhang, Q | 1 |
| Garigipati, S; Kundu, B; Semwal, A; Sharma, M; Sriram, D; Vanamala, D; Yogeeswari, P | 1 |
2 other study(ies) available for 1,2,4-triazole and Neuralgia
| Article | Year |
|---|---|
Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management.
Topics: Animals; Binding Sites; Blood-Brain Barrier; Drug Design; Guinea Pigs; Half-Life; Humans; Microsomes, Liver; Molecular Dynamics Simulation; Neuralgia; Pain Management; Protein Structure, Tertiary; Quantitative Structure-Activity Relationship; Rats; Receptors, sigma; Sigma-1 Receptor; Triazoles | 2021 |
Discovery of novel 1,2,4-triazol-5-ones as tumor necrosis factor-alpha inhibitors for the treatment of neuropathic pain.
Topics: Analgesics; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Edema; Humans; Mice; Neuralgia; Rats; Rats, Wistar; Structure-Activity Relationship; Triazoles; Tumor Necrosis Factor-alpha | 2012 |